BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1179 related articles for article (PubMed ID: 19277228)

  • 1. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
    Augsburger JJ; Corrêa ZM; Shaikh AH
    Trans Am Ophthalmol Soc; 2008; 106():128-35; discussion 135-7. PubMed ID: 19277228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of treatments for metastatic uveal melanoma.
    Augsburger JJ; Corrêa ZM; Shaikh AH
    Am J Ophthalmol; 2009 Jul; 148(1):119-27. PubMed ID: 19375060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
    Sacco JJ; Kalirai H; Kenyani J; Figueiredo CR; Coulson JM; Coupland SE
    Future Oncol; 2018 Jun; 14(14):1335-1338. PubMed ID: 29741103
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma.
    Lane AM; Kim IK; Gragoudas ES
    JAMA Ophthalmol; 2018 Sep; 136(9):981-986. PubMed ID: 29955797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited commentary. Uveal melanoma: implications of tumor doubling time.
    O'Brien J
    Ophthalmology; 2001 May; 108(5):831-2. PubMed ID: 11780648
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
    Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
    Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed systemic recurrence of uveal melanoma.
    Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
    Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.
    Eskelin S; Pyrhönen S; Summanen P; Hahka-Kemppinen M; Kivelä T
    Ophthalmology; 2000 Aug; 107(8):1443-9. PubMed ID: 10919885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
    Kim IK; Lane AM; Gragoudas ES
    Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of liver metastases from uveal melanoma: a retrospective single-center analysis.
    Yang XY; Xie F; Tao R; Li AJ; Wu MC
    Hepatobiliary Pancreat Dis Int; 2013 Dec; 12(6):602-6. PubMed ID: 24322745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveal melanoma: implications of tumor doubling time.
    Singh AD
    Ophthalmology; 2001 May; 108(5):829-31. PubMed ID: 11319992
    [No Abstract]   [Full Text] [Related]  

  • 12. Uveal melanoma: a rare malignancy.
    Gragoudas ES; Egan KM
    Ophthalmology; 2000 Aug; 107(8):1441-2. PubMed ID: 10919884
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival of patients with metastases from uveal melanoma.
    Gragoudas ES; Egan KM; Seddon JM; Glynn RJ; Walsh SM; Finn SM; Munzenrider JE; Spar MD
    Ophthalmology; 1991 Mar; 98(3):383-9; discussion 390. PubMed ID: 2023760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
    Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
    Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of metastatic malignant uveal melanoma].
    Jäckel A; Bock M; Deichmann M; Waldmann V; Näher H
    Hautarzt; 2001 Feb; 52(2):98-103. PubMed ID: 11244899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastases.
    Arulananda S; Parakh S; Palmer J; Goodwin M; Andrews MC; Cebon J
    Cancer Rep (Hoboken); 2019 Aug; 2(4):e1183. PubMed ID: 32721131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis.
    Rantala ES; Hernberg M; Kivelä TT
    Melanoma Res; 2019 Dec; 29(6):561-568. PubMed ID: 30664106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Metastatic Uveal Melanoma: Progress and Challenges.
    Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
    BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients.
    Bol KF; Mensink HW; Aarntzen EH; Schreibelt G; Keunen JE; Coulie PG; de Klein A; Punt CJ; Paridaens D; Figdor CG; de Vries IJ
    Am J Ophthalmol; 2014 Nov; 158(5):939-47. PubMed ID: 25038326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
    Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
    JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.